References
Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510–513
Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA 1996;46:5–27
Phillips RW, Wong RKH. Barrett's esophagus: natural history, incidence, etiology and complications. Gastroenterol Clin North Am 1991;20:791–815
Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547–1552
Orlando RC. Reflux esophagitis. In: Yamada T, Alpers DH, Owyang C, et al., eds. Textbook of gastroenterology. Philadelphia: JB Lippincott, 1991:1123
Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287–1289
Kahrilas P. It's not the American way—yet [editorial]. Am J Gastroenterol 1994;89:657–658
Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362–371
Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's esophagus). Gastroenterology 1990;99:918–922
Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastrooesophageal junction. Lancet 1994;344:1533–1536
Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992;1:265–269
Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995;109:1541–1546
Vicari J, Falk GW, Richter JE. Helicobacter pylori infection and acid peptic disorders of the esophagus: is it conceivable? Am J Gastroenterol 1997;92:1097–1102
Vicari JJ, Falk GW, Goldblum JR, et al. H. pylori is not a pathogenic factor in GERD or its complications. Gastroenterology 1997;112:A322
Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127–31
Hansson LE, Engstrand L, Nyren O, et al. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995;109:885–888
Lin J, Wang J, Wang TH, et al. Helicobacter pylori infection in early and advanced gastric adenocarcinoma: a seroprevalence study in 143 Taiwanese patients. Hepato-Gastroenterology 1993;40:596–599
Wang HH, Hsieh CC, Antonioli DA. Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter. Cancer Causes Control 1994;5:573–578
Chow WH, Finkle WD, McLaughlin JK, et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia. JAMA 1995;274:474–477
Attwood SEA, DeMeester TR, Bremner CG, et al. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery 1989;106:764–770
Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barret's esophagus. Gastroenterology 1994;107:747–754
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Falk, G.W., Richter, J.E. Why is esophageal adenocarcinoma increasing in incidence?. Abdom Imaging 23, 539–542 (1998). https://doi.org/10.1007/s002619900396
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002619900396